Iridex has introduced a new non-invasive, tissue-sparing glaucoma therapy called MicroPulse Laser Trabeculoplasty (MLT).
Iridex said MLT was first introduced in its infrared laser platforms, but now is available with the green laser system (IQ 532).
Gossage Eye Institute medical director David Gossage said the addition of the MicroPulse module to the IQ 532 system makes it a valid option for a much broader patient population than has historically been the case.
"Compared to other lasers used for the treatment of glaucoma, the IQ 532 with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears," Gossage added.
"I’m comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage."